Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology
LETSGO
1 other identifier
interventional
24
1 country
1
Brief Summary
This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO app is designed to promote empowerment in patients after treatment for gynecological cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2018
CompletedFirst Posted
Study publicly available on registry
March 5, 2018
CompletedStudy Start
First participant enrolled
March 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedSeptember 12, 2019
September 1, 2019
1.2 years
February 27, 2018
September 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satisfaction with LETSGOapp
Evaluate satisfaction with app through patient interviews
8 months
Secondary Outcomes (2)
Recruitment rate
6 months
Acceptability of goal setting
8 months
Study Arms (2)
Intervention group
EXPERIMENTALAlternating follow-up visits by nurse and doctor. In the nurse-led consultations, the patients will be introduced to the smartphone LETSGOapp with access to information on cancer treatment and side effects, physical activity advice. Two-monthly assessment of 12 symptoms that may represent relapse through the app.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment.
Reference group
NO INTERVENTIONRegular hospital follow-up.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment.
Interventions
LETSGO pilot test Group will test LETSGO app and partially nurseled follow-up
Eligibility Criteria
You may qualify if:
- Patients diagnosed and treated for gynecological cancer who will be followed up at the gynecological outpatient clinic in Kristiansand or Arendal
- No cognitive barriers.
You may not qualify if:
- \< 18 years
- Not able to read Norwegian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sorlandet Hospital HFlead
- University of Agdercollaborator
- Uppsala Universitycollaborator
Study Sites (1)
Sorlandet Hospital
Kristiansand, Vest Agder, 4604, Norway
Related Publications (1)
Skorstad M, Vistad I, Fegran L, Berntsen S, Johannessen B. Nurse-led consultations reinforced with eHealth technology: a qualitative study of the experiences of patients with gynecological cancer. BMC Nurs. 2022 Nov 25;21(1):326. doi: 10.1186/s12912-022-01104-9.
PMID: 36434602DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frode Gallefoss
Chief of Research Department, Sørlandet Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2018
First Posted
March 5, 2018
Study Start
March 20, 2018
Primary Completion
May 31, 2019
Study Completion
May 31, 2019
Last Updated
September 12, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share
This is a pilot study